$MIST insider trading

Over the last 12 months, Milestone Pharmaceuticals insiders reported no purchases and 7 sales totaling $1.2M across SEC Form 4 filings. 29% of those filings were made under pre-arranged 10b5-1 trading plans.

$1.2M
7
5
29%
Side
$1K$10K$100K$1.0M$10MMay '26JunJulAugNo insider events in this range
Oliveto Joseph
Muller Lorenz
Nelson Jeffrey Edward
Bharucha David
Hasija Amit

All insider trades

Scroll the table sideways for price, value and marks.

Apr 16, 2026Oliveto Joseph▼ Sale36,500$2.26$82K-7.6%
Jan 26, 2026Nelson Jeffrey Edward▼ Sale70,252$2.25$158K-58.5%
Jan 26, 2026Bharucha David▼ Sale70,252$2.25$158K-38.3%
Jan 26, 2026Hasija Amit▼ Sale70,252$2.25$158K-41.3%
Jan 26, 2026Muller Lorenz▼ Sale64,746$2.25$146K-24%
Jan 26, 2026Oliveto Joseph▼ Sale167,577$2.24$375K-25.8%
Jan 8, 2026Oliveto Joseph▼ Sale43,500$2.25$98K-12.5%

Every $MIST filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Milestone Pharmaceuticals filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MIST feed.

MIST Insider Trading — Milestone Pharmaceuticals Form 4 Buys & Sells | alphai